Institutional Manager · CIK 0001839209
Darwin Global Management, Ltd.
ST. HELIER, Y9 · File #028-21006
Latest AUM
$4.94B
Positions
6
Top-10 Concentration
100.0%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| NEW | BELITE BIO INC | BLTE | +3,027,704 | +$486.9M | $0 |
| EXITED | UNITED THERAPEUTICS CORP DEL | 91307C102 | -748,550 | -$317.6M | $0 |
| NEW | WAVE LIFE SCIENCES LTD | WVE | +7,298,421 | +$125.2M | $0 |
| ADD | INSMED INC | INSM | +475,832 | +$82.8M | +$663.6M |
| EXITED | UNIQURE NV | N90064101 | -400,000 | -$23.8M | $0 |
| NEW | CAPRICOR THERAPEUTICS INC | CAPR | +800,000 | +$23.2M | $0 |
| ADD | ABIVAX SA | AAVXF | +14,000 | +$1.9M | +$174.1M |
| REDUCE | CIDARA THERAPEUTICS INC | 171757206 | 0 | $0 | +$125.2M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20256 pos · $4.94B
- 13F HOLDINGS REPORTQ/E Sep 20255 pos · $3.60B
- 13F HOLDINGS REPORTQ/E Jun 20255 pos · $2.38B
- 13F HOLDINGS REPORTQ/E Mar 20253 pos · $1.46B
- 13F HOLDINGS REPORTQ/E Dec 20246 pos · $1.06B
- 13F HOLDINGS REPORTQ/E Sep 20245 pos · $1.23B
- 13F HOLDINGS REPORTQ/E Jun 20249 pos · $859.5M
- 13F HOLDINGS REPORTQ/E Mar 202412 pos · $751.2M
- 13F HOLDINGS REPORTQ/E Dec 20233 pos · $284.2M
Top 6 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 20,933,277 | $3.64B | 73.78% |
| 2 | BELITE BIO INC | BLTE | 3,027,704 | $486.9M | 9.86% |
| 3 | ABIVAX SA | AAVXF | 3,178,501 | $439.7M | 8.90% |
| 4 | CIDARA THERAPEUTICS INC | 171757206 | 997,196 | $220.2M | 4.46% |
| 5 | WAVE LIFE SCIENCES LTD | WVE | 7,298,421 | $125.2M | 2.53% |
| 6 | CAPRICOR THERAPEUTICS INC | CAPR | 800,000 | $23.2M | 0.47% |